Western Blot of Membrane Proteins
Corresponding Organization :
Other organizations : BOKU University, Comprehensive Cancer Center Vienna, Medical University of Vienna
Variable analysis
- Chronic arsenic treatment
- Protein expression levels (as measured by western blotting)
- Experimental procedures for protein lysate preparation, SDS-PAGE, and western blotting (as described previously in Heffeter et al. 2007)
- Primary antibodies (as listed in Supplementary Table 2)
- Secondary, horseradish peroxidase-labeled antibodies (used in 1:10,000 dilution)
- No positive controls were explicitly mentioned.
- Negative control: Total protein load via Coomassie staining (as outlined by Eaton et al. 2013) was used instead of reference proteins, which were affected by chronic arsenic treatment and could not be used for reliable normalization.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!